180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
180 Life Sciences is a biotech company in the growth stage, focusing on developing therapeutics to address inflammation-related diseases. The company has a diverse pipeline of three families of drugs targeting various inflammatory indications, with a lead program addressing early-stage Dupuytren's Contracture. With successful Phase 2b trial results and no serious adverse events reported, the program shows promise in filling a significant medical need.
Significant milestones in 180 Life Sciences' history include the successful development of a lead program for Dupuytren's Contracture, meeting primary and secondary endpoints with statistical significance. The company's pipeline consists of drugs targeting multiple inflammatory indications, demonstrating the expertise of world-class scientists from prestigious universities. The publication of trial results in The Lancet Rheumatology further solidifies 180 Life Sciences' position in advancing treatment for inflammatory diseases.
A notable case study for 180 Life Sciences is the development and successful completion of a Phase 2b trial for Dupuytren's Contracture, showing efficacy in addressing early-stage fibrosis of the hand. The trial results, published in The Lancet Rheumatology, demonstrate the company's dedication to advancing treatment options for inflammatory diseases. This case study highlights 180 Life Sciences' innovative approach to drug development and its potential impact on improving patient outcomes.
Key events for 180 Life Sciences include the successful completion of a Phase 2b trial for Dupuytren's Contracture, meeting primary and secondary endpoints with statistical significance. The publication of trial results in The Lancet Rheumatology signifies a major milestone for the company, showcasing its scientific expertise and dedication to advancing therapeutics for inflammatory diseases. Furthermore, the diverse pipeline of drugs targeting multiple indications demonstrates 180 Life Sciences' commitment to addressing unmet medical needs and potential market expansion.
-
Active
Health Care/Life Sciences
3000 El Camino Real Building 4 Suite 200 Palo Alto California 94306 United States...
United States
5
Omar J. Jimenez (Chief Financial Officer, Secretary & Director)
Lawrence J. Steinman (Director)
-
$4.97
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care/Life Sciences
3000 El Camino Real Building 4 Suite 200 Palo Alto California 94306 United States...
United States
5+
-
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC